KOR ENG

Corporate Disclosure

U2Bio maximizes shareholder profits and corporate value based on a stable and long-term growth strategy.

HomeInvestment InformationCorporate Disclosure
Number Title A person obligated to submit Date
6 사업보고서 (2023.12) 유투바이오 2024-03-20
5 주주총회소집공고 유투바이오 2024-03-13
4 감사보고서제출 유투바이오 2024-03-13
3 현금ㆍ현물배당결정 유투바이오 2024-02-15
2 주주총회소집결의 유투바이오 2024-02-15
1 매출액또는손익구조30%(대규모법인은15%)이상변동 유투바이오 2024-01-30

This site is not supported by your current browser. Please download and use another browser below.